(THRM) Gentherm - Ratings and Ratios
Thermal Management, Seat Heaters, Ventilation, Battery Cooling, Medical Devices
THRM EPS (Earnings per Share)
THRM Revenue
Description: THRM Gentherm August 27, 2025
Gentherm Inc, listed on NASDAQ under the ticker symbol THRM, is a US-based company operating in the automotive parts and equipment sub-industry. The companys primary focus is on developing and manufacturing thermal management and seating solutions for the automotive industry.
To evaluate Gentherms performance, key financial metrics such as revenue growth, operating margins, and return on equity (ROE) are crucial. With a current ROE of 4.82%, the company may be facing challenges in generating profits from shareholder equity. However, the forward price-to-earnings ratio of 15.15 suggests that investors expect earnings growth in the future.
The automotive parts and equipment industry is driven by factors such as global vehicle production, technological advancements, and regulatory requirements. Gentherms success is closely tied to the demand for its thermal management and seating solutions, which are influenced by trends such as electrification, autonomous driving, and comfort features. Key performance indicators (KPIs) to monitor include the companys market share, product innovation pipeline, and customer relationships with major automotive manufacturers.
Economic drivers that impact Gentherms business include global GDP growth, automotive sales, and production volumes. Fluctuations in raw material prices, trade policies, and regulatory changes can also affect the companys profitability. To mitigate these risks, Gentherm may focus on diversifying its customer base, investing in research and development, and improving operational efficiency.
THRM Stock Overview
| Market Cap in USD | 1,117m |
| Sub-Industry | Automotive Parts & Equipment |
| IPO / Inception | 1993-06-10 |
THRM Stock Ratings
| Growth Rating | -64.3% |
| Fundamental | 60.2% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -29.0% |
| Analyst Rating | 3.83 of 5 |
THRM Dividends
Currently no dividends paidTHRM Growth Ratios
| Growth Correlation 3m | 6.4% |
| Growth Correlation 12m | -31.8% |
| Growth Correlation 5y | -88.3% |
| CAGR 5y | -20.89% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.30 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.58 |
| Sharpe Ratio 12m | -0.12 |
| Alpha | -41.55 |
| Beta | 1.388 |
| Volatility | 35.04% |
| Current Volume | 141.9k |
| Average Volume 20d | 197.1k |
| Stop Loss | 34.6 (-4.3%) |
| Signal | 0.60 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (30.6m TTM) > 0 and > 6% of Revenue (6% = 87.9m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.32% (prev 25.27%; Δ 1.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 124.4m > Net Income 30.6m (YES >=105%, WARN >=100%) |
| Net Debt (-94.3m) to EBITDA (153.2m) ratio: -0.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (30.7m) change vs 12m ago -1.97% (target <= -2.0% for YES) |
| Gross Margin 24.13% (prev 25.94%; Δ -1.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 109.3% (prev 113.2%; Δ -3.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.24 (EBITDA TTM 153.2m / Interest Expense TTM 13.9m) >= 6 (WARN >= 3) |
Altman Z'' 3.98
| (A) 0.28 = (Total Current Assets 785.9m - Total Current Liabilities 400.3m) / Total Assets 1.38b |
| (B) 0.50 = Retained Earnings (Balance) 695.8m / Total Assets 1.38b |
| (C) 0.08 = EBIT TTM 101.0m / Avg Total Assets 1.34b |
| (D) 0.00 = Book Value of Equity 1.36m / Total Liabilities 663.4m |
| Total Rating: 3.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 60.24
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 6.62% = 3.31 |
| 3. FCF Margin 4.62% = 1.16 |
| 4. Debt/Equity 0.08 = 2.50 |
| 5. Debt/Ebitda -0.62 = 2.50 |
| 6. ROIC - WACC (= -2.59)% = -3.24 |
| 7. RoE 4.57% = 0.38 |
| 8. Rev. Trend 40.87% = 3.07 |
| 9. EPS Trend 1.64% = 0.08 |
What is the price of THRM shares?
Over the past week, the price has changed by -1.74%, over one month by +4.93%, over three months by +9.24% and over the past year by -19.09%.
Is Gentherm a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of THRM is around 26.72 USD . This means that THRM is currently overvalued and has a potential downside of -26.11%.
Is THRM a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the THRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.6 | 26.1% |
| Analysts Target Price | 45.6 | 26.1% |
| ValueRay Target Price | 30.4 | -15.9% |
THRM Fundamental Data Overview November 01, 2025
P/E Trailing = 36.9697
P/E Forward = 13.6799
P/S = 0.7607
P/B = 1.5388
P/EG = 0.71
Beta = 1.388
Revenue TTM = 1.46b USD
EBIT TTM = 101.0m USD
EBITDA TTM = 153.2m USD
Long Term Debt = 220.1m USD (from longTermDebt, last fiscal year)
Short Term Debt = 10.3m USD (from shortTermDebt, last quarter)
Debt = 60.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -94.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.02b USD (1.12b + Debt 60.0m - CCE 154.2m)
Interest Coverage Ratio = 7.24 (Ebit TTM 101.0m / Interest Expense TTM 13.9m)
FCF Yield = 6.62% (FCF TTM 67.7m / Enterprise Value 1.02b)
FCF Margin = 4.62% (FCF TTM 67.7m / Revenue TTM 1.46b)
Net Margin = 2.09% (Net Income TTM 30.6m / Revenue TTM 1.46b)
Gross Margin = 24.13% ((Revenue TTM 1.46b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 23.81% (prev 23.93%)
Tobins Q-Ratio = 0.74 (Enterprise Value 1.02b / Total Assets 1.38b)
Interest Expense / Debt = 5.52% (Interest Expense 3.31m / Debt 60.0m)
Taxrate = 28.42% (5.93m / 20.9m)
NOPAT = 72.3m (EBIT 101.0m * (1 - 28.42%))
Current Ratio = 1.96 (Total Current Assets 785.9m / Total Current Liabilities 400.3m)
Debt / Equity = 0.08 (Debt 60.0m / totalStockholderEquity, last quarter 717.9m)
Debt / EBITDA = -0.62 (Net Debt -94.3m / EBITDA 153.2m)
Debt / FCF = -1.39 (Net Debt -94.3m / FCF TTM 67.7m)
Total Stockholder Equity = 670.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.22% (Net Income 30.6m / Total Assets 1.38b)
RoE = 4.57% (Net Income TTM 30.6m / Total Stockholder Equity 670.3m)
RoCE = 11.34% (EBIT 101.0m / Capital Employed (Equity 670.3m + L.T.Debt 220.1m))
RoIC = 8.17% (NOPAT 72.3m / Invested Capital 884.9m)
WACC = 10.76% (E(1.12b)/V(1.18b) * Re(11.13%) + D(60.0m)/V(1.18b) * Rd(5.52%) * (1-Tc(0.28)))
Discount Rate = 11.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.28%
[DCF Debug] Terminal Value 68.52% ; FCFE base≈60.8m ; Y1≈63.0m ; Y5≈71.9m
Fair Price DCF = 25.68 (DCF Value 783.8m / Shares Outstanding 30.5m; 5y FCF grow 3.83% → 3.0% )
EPS Correlation: 1.64 | EPS CAGR: 17.36% | SUE: 0.40 | # QB: 0
Revenue Correlation: 40.87 | Revenue CAGR: 4.05% | SUE: 0.82 | # QB: 0
Additional Sources for THRM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle